SCHEMBL9558689

SCHEMBL9558689

Fc1ccc(-c2nc(Cl)nc3c2CCCC3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 9/20 0.47
HTR2C P28335 9/20 0.47
HTR2B P41595 9/20 0.47
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 2/20 0.45
HPGD P15428 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ADORA2A P29274 1/20 0.45
HRH2 P25021 2/20 0.44
HRH3 Q9Y5N1 2/20 0.44
ACHE P22303 4/20 0.43
BCHE P06276 3/20 0.43
GRIN1 Q05586 3/20 0.43
GRIN2A Q12879 3/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9558713 0.98 HTR2A (0.46) HTR2AHTR2CHTR2BKDM4ENPC1
SCHEMBL9558730 0.97 KDM4E (0.48) HTR2AHTR2CHTR2BKDM4ENPC1
SCHEMBL4134361 0.80 ALDH1A1 (0.52) KDM4ENPC1HPGDRAB9ASMN1; SMN2
SCHEMBL183610 0.77 HTR2A (0.75) HTR2AHTR2CHTR2BKDM4ENPC1
SCHEMBL25260102 0.77 HRH2 (0.45) HTR2AHTR2CHTR2BKDM4EALDH1A1
SCHEMBL9558720 0.77 HRH2 (0.52) HTR2AHTR2CHTR2BKDM4EALDH1A1
SCHEMBL716608 0.75 KMT2A (0.52) HTR2AHTR2CHTR2BKDM4ENPC1
SCHEMBL24698706 0.75 HRH2 (0.40) KDM4EHPGDRAB9AALDH1A1TP53
SCHEMBL7500873 0.74 KDM4E (0.45) HTR2AHTR2CHTR2BKDM4ENPC1
SCHEMBL7332801 0.73 DRD2 (0.52) HTR2AKDM4ENPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5185338-A Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-02-09 US disclosed
US-5041443-A Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1991-08-20 US disclosed
EP-0384228-A1 Medicament for treating cerebral insufficiency diseases containing 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1990-08-29 EP disclosed